In vitro evaluation of cytotoxicity of silver-containing borate bioactive glass

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 95 B, Issue 2, 2010, Pages 441-448

  Luo, Shi Hua ^a   Xiao, Wei ^b   Wei, Xiao Juan ^a   Jia, Wei Tao ^a   Zhang, Chang Qing ^a   Huang, Wen Hai ^b   Jin, Dong Xu ^a   Rahaman, Mohamed N ^c   Day, Delbert E ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c Architectural and Environmental Engineering   (United States)

Author keywords

cytotoxicity; fibroblast; osteoblast; silver containing borate glass

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; BACTERIAL INHIBITION; BORATE GLASS; CELL MORPHOLOGY; COATING MATERIAL; CYTOTOXIC EFFECTS; DISSOLUTION PRODUCTS; FIBROBLASTIC CELLS; GLASS FRIT; GLASS SURFACES; IN-VITRO; IN-VITRO EVALUATION; LACTATE DEHYDROGENASE; MC3T3-E1; MICROCHEMICAL ANALYSIS; ORTHOPAEDIC IMPLANTS; QUENCHING PROCESS; SEM OBSERVATION; SIMULATED BODY FLUIDS; WEIGHT PERCENT;

ATOMIC EMISSION SPECTROSCOPY; ATOMIC SPECTROSCOPY; CELL CULTURE; CYTOTOXICITY; DISSOLUTION; FIBROBLASTS; HYDROXYAPATITE; PHOSPHATASES; SILVER; TITANIUM;

BIOACTIVE GLASS;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALINE PHOSPHATASE; BORIC ACID; GLASS; HYDROXYAPATITE; LACTATE DEHYDROGENASE; SILVER; TITANIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DISSOLUTION; ENZYME ACTIVITY; EVALUATION; FIBROBLAST; HYDROLYSIS; IMPLANT; IN VITRO STUDY; MATERIAL COATING; MOUSE; NONHUMAN; OSTEOBLAST;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; BORIC ACIDS; CELLS, CULTURED; GLASS; L-LACTATE DEHYDROGENASE; MICE; MICROSCOPY, ELECTRON, SCANNING; SILVER;

EID: 78649674063     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31735     Document Type: Article

References (26)

1. Alta V, Bechert T, Steinrucke P, Wagener M, Seidel P,. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004; 25: 4383-4391.
2. Esposito M, Hirsch JM, Lekholm U, Thomsen P,. Biological factors contributing to failures of osseointegrated oral implants. II. Etiopathogenesis. Eur J Oral Sci 1998; 106: 721-764. (Pubitemid 128736235)
3. Costerton JW, Ellis B, Lam K, Johnson F, Khoury AE,. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm. Antimicrob Agents Chemother 1994; 38: 2803-2809.
4. Schierholz JM, Morsczeck C, Brenner N, König DP, Yücel N, Korenkov M,. Special aspects of implant-associated infection in orthopedic surgery. Orthopäde 2004; 33: 397-404.
5. Eggimann P, Pittet D,. Infection control in the ICU. Chest 2001; 120: 2059-2093.
6. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y,. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101: 2916-2921.
7. Holtom PD, Patzakis MJ,. Newer methods of antimicrobial delivery for bone and joint infections. Instr Course Lect 2003; 52: 745-749.
8. Mäkinen TJ, Veiranto M, Knuuti J, Jalava J, Törmälä P, Aro HT,. Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus. Bone 2005; 36: 292-299.
9. Bechert T, Böswald M, Lugauer S, Regenfus A, Greil J, Guggenbichler JP,. The Erlanger silver catheter: In vitro results for antimicrobial activity. Infection 1999; 27 (Suppl 1): S24-S29.
10. Adams AP, Santchi EM, Millencamp MA,. Antibacterial properties of silver chloride coated nylon wound dressing. Vet Surg 1999; 28: 219-225.
11. Yorganci K, Krepel C, Weiget JA, Edmiston CE,. In vitro evaluation of the antibacterial activity of three defferent central venous catheters against gram-positive bacterial. Eur J Clin Microbiol Infect Dis 2002; 21: 379-384.
12. Silver S,. Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003; 27: 341-353.
13. Huang W, Rahaman MN, Day DE, Li Y,. Mechanisms for converting bioactive silicate, borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions. Phys Chem Glasses: Eur J Glass Sci Technol B 2006; 47: 647-658.
14. Yao A, Wang D, Huang W, Fu Q, Rahaman MN, Day DE,. In vitro bioactive characteristics of borate-based glasses with controllable degradation behavior. J Am Ceram Soc 2007; 90: 303-306. (Pubitemid 46087976)
15. Kokubo T, Takadama H, How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006; 27: 2907-2915.
16. Barragan-Adjemian C, Nicolella D, Dusevich V, Dallas MR, Eick JD, Bonewald LF,. Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: Similarities with mineralization of lamellar bone. Calcif Tissue Int 2006; 79: 340-353.
17. Walenkamp GHIM,. Gentamicin PMMA Beads. A Clinical Pharmacokinetic and Toxicological Study, Thesis. The Netherlands. University of Nijmegen: University of Nijmegen; 1983.
18. Kumar R, Münstedt H,. Silver ion release from antimicrobial polyamide/silver composites. Biomaterials 2005; 26: 2081-2088. (Pubitemid 39575350)
19. Zhao Y, Zhang X, Xiang W, Wang D, Huang W, Pan H, et al. Research of borosilicate glass with strontium on bioactivity and biodegradability in vitro, Functional Materials (Chinese version). Forthcoming.
20. Dean JA,. Lange's Handbook of Chemistry, 15th ed. 1998.
21. Vik H, Andersen KJ, Julshamn K, Todnem K,. Neuropathy caused by silver absorption from arthroplasty cement. Lancet 1985; 1: 872.
22. Mosmann T,. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays. J Immunol Methods 1983; 65: 55-63.
23. Van de Loosdrecht AA, Nennie E, Ossenkoppele GJ, Beelen RH, Langenhuijsen MM,. Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study. J Immunol Methods 1991; 141: 15-22.
24. Groessner-Schreiber B, Tuan RS,. Enhanced extracellular matrix production and mineralization by osteoblasts cultured on titanium surfaces in vitro. J Cell Sci 1992; 101: 209-217.
25. ISO 10993-5. International Organization for Standardization, ISO 10993-5: Biological Evaluation of Medical Devices. V. Tests for Cytotoxicity In Vitro Methods. Geneva; 1992.
26. ISO 10993-5. International Organization for Standardization, ISO 7405: Dentistry-Preclinical Evaluation of Biocompatibility of Medical Devices Used in Dentistry-Test Methods for Dental Materials. Geneva; 1997.